Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016.

Cazabon D, Pande T, Kik S, Van Gemert W, Sohn H, Denkinger C, Qin ZZ, Waning B, Pai M.

Version 2. Gates Open Res. 2018 Sep 18 [revised 2018 Jan 1];2:35. doi: 10.12688/gatesopenres.12842.2. eCollection 2018.

2.

Protection of the Ovine Fetal Gut against Ureaplasma-Induced Chorioamnionitis: A Potential Role for Plant Sterols.

van Gorp C, de Lange IH, Spiller OB, Dewez F, Cillero Pastor B, Heeren RMA, Kessels L, Kloosterboer N, van Gemert WG, Beeton ML, Stock SJ, Jobe AH, Payne MS, Kemp MW, Zimmermann LJ, Kramer BW, Plat J, Wolfs TGAM.

Nutrients. 2019 Apr 27;11(5). pii: E968. doi: 10.3390/nu11050968.

3.

Evaluation of a new robotic-assisted laparoscopic surgical system for procedures in small cavities.

Bergholz R, Botden S, Verweij J, Tytgat S, Van Gemert W, Boettcher M, Ehlert H, Reinshagen K, Gidaro S.

J Robot Surg. 2019 Apr 16. doi: 10.1007/s11701-019-00961-y. [Epub ahead of print]

PMID:
30993523
4.

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF.

Ponnudurai N, Denkinger CM, Van Gemert W, Pai M.

J Epidemiol Glob Health. 2018 Dec;8(3-4):103-105. doi: 10.2991/j.jegh.2018.04.005. No abstract available.

PMID:
30864749
5.

Effect of diet with or without exercise on abdominal fat in postmenopausal women - a randomised trial.

van Gemert WA, Peeters PH, May AM, Doornbos AJH, Elias SG, van der Palen J, Veldhuis W, Stapper M, Schuit JA, Monninkhof EM.

BMC Public Health. 2019 Feb 11;19(1):174. doi: 10.1186/s12889-019-6510-1.

6.

Long-term functional outcomes and quality of life in patients with Hirschsprung's disease.

Meinds RJ, van der Steeg AFW, Sloots CEJ, Witvliet MJ, de Blaauw I, van Gemert WG, Trzpis M, Broens PMA.

Br J Surg. 2019 Mar;106(4):499-507. doi: 10.1002/bjs.11059. Epub 2019 Jan 17.

7.

FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease.

Koelfat KVK, Visschers RGJ, Hodin CMJM, de Waart DR, van Gemert WG, Cleutjens JPM, Gijbels MJ, Shiri-Sverdlov R, Mookerjee RP, Lenaerts K, Schaap FG, Steven W M OD.

J Clin Transl Res. 2017 Oct 15;3(3):318-327. eCollection 2018 Jan 15.

8.

Choledochal Malformation in Children: Lessons Learned from a Dutch National Study.

Nederlandse Studiegroep voor Choledochus Cysten/malformaties (NeSCHoC), van den Eijnden MHA, de Kleine RHJ, de Blaauw I, Peeters PGJM, Koot BPG, Oomen MWN, Sloots CEJ, van Gemert WG, van der Zee DC, van Heurn LWE, Verkade HJ, Wilde JCH, Hulscher JBF.

World J Surg. 2017 Oct;41(10):2631-2637. doi: 10.1007/s00268-017-4064-x.

9.

Association between changes in fat distribution and biomarkers for breast cancer.

van Gemert WA, Monninkhof EM, May AM, Elias SG, van der Palen J, Veldhuis W, Stapper M, Stellato RK, Schuit JA, Peeters PH.

Endocr Relat Cancer. 2017 Jun;24(6):297-305. doi: 10.1530/ERC-16-0490. Epub 2017 May 16.

10.

The timing of surgery of antenatally diagnosed choledochal malformations: A descriptive analysis of a 26-year nationwide cohort.

Netherlands Study Group for Choledochus Cysts/Malformations (NeSCHoC), van den Eijnden MHA, de Kleine RH, de Blaauw I, Peeters PMJG, Koot BGP, Oomen MWN, Sloots CEJ, van Gemert WG, van der Zee DC, van Heurn LWE, Verkade HJ, Wilde JCH, Hulscher JBF.

J Pediatr Surg. 2017 Jul;52(7):1156-1160. doi: 10.1016/j.jpedsurg.2017.03.003. Epub 2017 Mar 12.

PMID:
28318597
11.

Long-term effects of a weight loss intervention with or without exercise component in postmenopausal women: A randomized trial.

de Roon M, van Gemert WA, Peeters PH, Schuit AJ, Monninkhof EM.

Prev Med Rep. 2016 Dec 9;5:118-123. eCollection 2017 Mar.

12.

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.

Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, Bloom A, Aziz MA, Weyer K, Jaramillo E, Nunn P, Floyd K, Raviglione MC.

N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438. No abstract available.

13.

Digital health for the End TB Strategy: developing priority products and making them work.

Falzon D, Timimi H, Kurosinski P, Migliori GB, Van Gemert W, Denkinger C, Isaacs C, Story A, Garfein RS, do Valle Bastos LG, Yassin MA, Rusovich V, Skrahina A, Van Hoi L, Broger T, Abubakar I, Hayward A, Thomas BV, Temesgen Z, Quraishi S, von Delft D, Jaramillo E, Weyer K, Raviglione MC.

Eur Respir J. 2016 Jul;48(1):29-45. doi: 10.1183/13993003.00424-2016. Epub 2016 May 26.

14.

Effect of Weight Loss with or without Exercise on Inflammatory Markers and Adipokines in Postmenopausal Women: The SHAPE-2 Trial, A Randomized Controlled Trial.

van Gemert WA, May AM, Schuit AJ, Oosterhof BY, Peeters PH, Monninkhof EM.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):799-806. doi: 10.1158/1055-9965.EPI-15-1065. Epub 2016 Feb 16.

15.

Effect of weight loss, with or without exercise, on body composition and sex hormones in postmenopausal women: the SHAPE-2 trial.

van Gemert WA, Schuit AJ, van der Palen J, May AM, Iestra JA, Wittink H, Peeters PH, Monninkhof EM.

Breast Cancer Res. 2015 Sep 2;17:120. doi: 10.1186/s13058-015-0633-9.

16.

The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors.

van Gemert WA, Lanting CI, Goldbohm RA, van den Brandt PA, Grooters HG, Kampman E, Kiemeney LALM, van Leeuwen FE, Monninkhof EM, de Vries E, Peeters PH, Elias SG.

Breast Cancer Res Treat. 2015 Jul;152(1):155-162. doi: 10.1007/s10549-015-3447-7. Epub 2015 Jun 5.

17.

Quality of Life after Diet or Exercise-Induced Weight Loss in Overweight to Obese Postmenopausal Women: The SHAPE-2 Randomised Controlled Trial.

van Gemert WA, van der Palen J, Monninkhof EM, Rozeboom A, Peters R, Wittink H, Schuit AJ, Peeters PH.

PLoS One. 2015 Jun 1;10(6):e0127520. doi: 10.1371/journal.pone.0127520. eCollection 2015.

18.

Intestinal lengthening and reversed segment in a piglet short bowel syndrome model.

Koffeman GI, Hulscher JB, Schoots IG, van Gulik TM, Heij HA, van Gemert WG.

J Surg Res. 2015 May 15;195(2):433-43. doi: 10.1016/j.jss.2014.12.024. Epub 2014 Dec 29.

PMID:
25819769
19.

How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?

Qin ZZ, Pai M, Van Gemert W, Sahu S, Ghiasi M, Creswell J.

Eur Respir J. 2015 Feb;45(2):549-54. doi: 10.1183/09031936.00147714. Epub 2014 Oct 30. No abstract available.

20.

Effect of exercise on insulin sensitivity in healthy postmenopausal women: the SHAPE study.

van Gemert WA, Monninkhof EM, May AM, Peeters PH, Schuit AJ.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):81-7. doi: 10.1158/1055-9965.EPI-14-0722. Epub 2014 Oct 23.

21.

Rectovaginal fistula: a new technique and preliminary results using collagen matrix biomesh.

Göttgens KW, Heemskerk J, van Gemert W, Smeets R, Stassen LP, Beets G, Baeten CG, Breukink SO.

Tech Coloproctol. 2014 Sep;18(9):817-23. doi: 10.1007/s10151-014-1145-9. Epub 2014 Mar 28.

PMID:
24676842
22.

Long-term results of mucosal advancement flap combined with platelet-rich plasma for high cryptoglandular perianal fistulas.

Göttgens KW, Vening W, van der Hagen SJ, van Gemert WG, Smeets RR, Stassen LP, Baeten CG, Breukink SO.

Dis Colon Rectum. 2014 Feb;57(2):223-7. doi: 10.1097/DCR.0000000000000023.

PMID:
24401885
23.

Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011.

Ulmasova DJ, Uzakova G, Tillyashayhov MN, Turaev L, van Gemert W, Hoffmann H, Zignol M, Kremer K, Gombogaram T, Gadoev J, du Cros P, Muslimova N, Jalolov A, Dadu A, de Colombani P, Telnov O, Slizkiy A, Kholikulov B, Dara M, Falzon D.

Euro Surveill. 2013 Oct 17;18(42). pii: 20609.

24.

Design of the SHAPE-2 study: the effect of physical activity, in addition to weight loss, on biomarkers of postmenopausal breast cancer risk.

van Gemert WA, Iestra JI, Schuit AJ, May AM, Takken T, Veldhuis WB, van der Palen J, Wittink H, Peeters PH, Monninkhof EM.

BMC Cancer. 2013 Aug 23;13:395. doi: 10.1186/1471-2407-13-395.

25.

Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors.

Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S, Rusovich V, Dadu A, de Colombani P, Dara M, van Gemert W, Zignol M.

Bull World Health Organ. 2013 Jan 1;91(1):36-45. doi: 10.2471/BLT.12.104588. Epub 2012 Nov 26.

26.

Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.

Weyer K, Mirzayev F, Migliori GB, Van Gemert W, D'Ambrosio L, Zignol M, Floyd K, Centis R, Cirillo DM, Tortoli E, Gilpin C, de Dieu Iragena J, Falzon D, Raviglione M.

Eur Respir J. 2013 Jul;42(1):252-71. doi: 10.1183/09031936.00157212. Epub 2012 Nov 22. Review.

27.

Long-term results after restorative proctocolectomy with ileal pouch-anal anastomosis at a young age.

van Balkom KA, Beld MP, Visschers RG, van Gemert WG, Breukink SO.

Dis Colon Rectum. 2012 Sep;55(9):939-47. doi: 10.1097/DCR.0b013e31825bd7f4.

PMID:
22874600
28.

Guided treatment improves outcome of patients with enterocutaneous fistulas.

Visschers RG, van Gemert WG, Winkens B, Soeters PB, Olde Damink SW.

World J Surg. 2012 Oct;36(10):2341-8. doi: 10.1007/s00268-012-1663-4.

29.

A prospective non-randomized two-centre study of patients with passive faecal incontinence after birth trauma and patients with soiling after anal surgery, treated by elastomer implants versus rectal irrigation.

van der Hagen SJ, van der Meer W, Soeters PB, Baeten CG, van Gemert WG.

Int J Colorectal Dis. 2012 Sep;27(9):1191-8. doi: 10.1007/s00384-012-1468-9. Epub 2012 May 11.

30.

Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.

Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M.

Bull World Health Organ. 2012 Feb 1;90(2):111-119D. doi: 10.2471/BLT.11.092585. Epub 2011 Nov 7.

31.

Transvaginal posterior colporrhaphy combined with laparoscopic ventral mesh rectopexy for isolated Grade III rectocele: a prospective study of 27 patients.

van der Hagen SJ, van Gemert WG, Soeters PB, de Wet H, Baeten CG.

Colorectal Dis. 2012 Nov;14(11):1398-402. doi: 10.1111/j.1463-1318.2012.03023.x.

PMID:
22405411
32.

Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling.

Hedt BL, van Leth F, Zignol M, Cobelens F, van Gemert W, Nhung NV, Lyepshina S, Egwaga S, Cohen T.

Epidemiology. 2012 Mar;23(2):293-300. doi: 10.1097/EDE.0b013e3182459455.

33.

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, van Gemert W, Hoffner S, Rusovich V, Zignol M.

Eur Respir J. 2012 Jun;39(6):1425-31. doi: 10.1183/09031936.00145411. Epub 2011 Oct 17.

34.

Staged Mucosal Advancement Flap versus Staged Fibrin Sealant in the Treatment of Complex Perianal Fistulas.

van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG.

Gastroenterol Res Pract. 2011;2011:186350. doi: 10.1155/2011/186350. Epub 2011 Jul 26.

35.

Treatment of hypertriglyceridemia in patients receiving parenteral nutrition.

Visschers RG, Olde Damink SW, Gehlen JM, Winkens B, Soeters PB, van Gemert WG.

JPEN J Parenter Enteral Nutr. 2011 Sep;35(5):610-5. doi: 10.1177/0148607110389616. Epub 2011 Jul 28.

PMID:
21799190
36.

Conservative treatment of patients with faecal soiling.

van der Hagen SJ, Soeters PB, Baeten CG, van Gemert WG.

Tech Coloproctol. 2011 Sep;15(3):291-5. doi: 10.1007/s10151-011-0709-1. Epub 2011 Jul 1.

37.

Laparoscopic fistula excision and omentoplasty for high rectovaginal fistulas: a prospective study of 40 patients.

van der Hagen SJ, Soeters PB, Baeten CG, van Gemert WG.

Int J Colorectal Dis. 2011 Nov;26(11):1463-7. doi: 10.1007/s00384-011-1259-8. Epub 2011 Jun 24.

38.

Sacral nerve modulation for defaecation and micturition disorders in patients with spina bifida.

Lansen-Koch SM, Govaert B, Oerlemans D, Melenhorst J, Vles H, Cornips E, Weil EH, van Heurn E, Baeten CG, van Gemert WG.

Colorectal Dis. 2012 Apr;14(4):508-14. doi: 10.1111/j.1463-1318.2011.02678.x.

PMID:
21689346
39.

Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing.

Zignol M, van Gemert W, Falzon D, Jaramillo E, Blanc L, Raviglione M.

Clin Infect Dis. 2011 Apr 1;52(7):901-6. doi: 10.1093/cid/cir081.

40.

Influence of reoperations on long-term quality of life after restrictive procedures: a prospective study.

Schouten R, Wiryasaputra DC, van Dielen FM, van Gemert WG, Greve JW.

Obes Surg. 2011 Jul;21(7):871-9. doi: 10.1007/s11695-010-0350-5.

41.

Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.

Nieuwenhuis MH, Mathus-Vliegen EM, Baeten CG, Nagengast FM, van der Bijl J, van Dalsen AD, Kleibeuker JH, Dekker E, Langers AM, Vecht J, Peters FT, van Dam R, van Gemert WG, Stuifbergen WN, Schouten WR, Gelderblom H, Vasen HF.

Br J Cancer. 2011 Jan 4;104(1):37-42. doi: 10.1038/sj.bjc.6605997. Epub 2010 Nov 9.

42.

Sacral neuromodulation: long-term outcome and quality of life in patients with faecal incontinence.

Uludağ O, Melenhorst J, Koch SM, van Gemert WG, Dejong CH, Baeten CG.

Colorectal Dis. 2011 Oct;13(10):1162-6. doi: 10.1111/j.1463-1318.2010.02447.x.

PMID:
20955512
43.

Long-term results of bariatric restrictive procedures: a prospective study.

Schouten R, Wiryasaputra DC, van Dielen FM, van Gemert WG, Greve JW.

Obes Surg. 2010 Dec;20(12):1617-26. doi: 10.1007/s11695-010-0211-2.

44.

Sacral neuromodulation: does it affect the rectoanal angle in patients with fecal incontinence?

Uludağ O, Koch SM, Vliegen RF, Dejong CH, van Gemert WG, Baeten CG.

World J Surg. 2010 May;34(5):1109-14. doi: 10.1007/s00268-010-0474-8. Erratum in: World J Surg. 2010 May;34(5):1115.

PMID:
20162279
45.

Localization of the lipopolysaccharide recognition complex in the human healthy and inflamed premature and adult gut.

Wolfs TG, Derikx JP, Hodin CM, Vanderlocht J, Driessen A, de Bruïne AP, Bevins CL, Lasitschka F, Gassler N, van Gemert WG, Buurman WA.

Inflamm Bowel Dis. 2010 Jan;16(1):68-75. doi: 10.1002/ibd.20995.

PMID:
20014022
46.

Factors associated with percutaneous nerve evaluation and permanent sacral nerve modulation outcome in patients with fecal incontinence.

Govaert B, Melenhorst J, Nieman FH, Bols EM, van Gemert WG, Baeten CG.

Dis Colon Rectum. 2009 Oct;52(10):1688-94. doi: 10.1007/DCR.0b013e3181b55595.

PMID:
19966599
47.

The role of reprogramming in sacral nerve modulation for faecal incontinence.

Govaert B, Rietveld MP, van Gemert WG, Baeten CG.

Colorectal Dis. 2011 Jan;13(1):78-81. doi: 10.1111/j.1463-1318.2009.02072.x.

PMID:
19843113
48.

Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes.

Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, Halaska M, Vergote I, Ottevanger N, Amant F.

J Clin Oncol. 2010 Feb 1;28(4):683-9. doi: 10.1200/JCO.2009.23.2801. Epub 2009 Oct 19.

PMID:
19841323
49.

[Retrograde irrigation of the colon: treatment for faecal incontinence after low anterior resection].

Baeten CG, Govaert B, van Gemert WG.

Ned Tijdschr Geneeskd. 2009;153:A289. Dutch.

PMID:
19785868
50.

Optimisation of a green gas supply chain--a review.

Bekkering J, Broekhuis AA, van Gemert WJ.

Bioresour Technol. 2010 Jan;101(2):450-6. doi: 10.1016/j.biortech.2009.08.106. Epub 2009 Sep 18. Review.

PMID:
19766478

Supplemental Content

Loading ...
Support Center